These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 27754367)

  • 1. The Last Ten Years of Advancements in Plant-Derived Recombinant Vaccines against Hepatitis B.
    Joung YH; Park SH; Moon KB; Jeon JH; Cho HS; Kim HS
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral hepatitis B vaccine candidates produced and delivered in plant material.
    Streatfield SJ
    Immunol Cell Biol; 2005 Jun; 83(3):257-62. PubMed ID: 15877603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparison of antibody response to different hepatitis b vaccines with and without pre-S2 antigen in children with cancer.
    Emir S; Büyükpamuk M; Akyüz C; Kutluk T; Güler E; Cağlar K
    Pediatr Hematol Oncol; 2002 Jun; 19(4):227-33. PubMed ID: 12051588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do we need better hepatitis B vaccines?
    Gerlich WH
    Indian J Med Res; 2017 Apr; 145(4):414-419. PubMed ID: 28862172
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity.
    Cassidy A; Mossman S; Olivieri A; De Ridder M; Leroux-Roels G
    Expert Rev Vaccines; 2011 Dec; 10(12):1709-15. PubMed ID: 22085174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B vaccines: protective efficacy and therapeutic potential.
    Michel ML; Tiollais P
    Pathol Biol (Paris); 2010 Aug; 58(4):288-95. PubMed ID: 20382485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning, protein expression and immunogenicity of HBs-murine IL-18 fusion DNA vaccine.
    Channarong S; Mitrevej A; Sinchaipanid N; Usuwantim K; Kulkeaw K; Chaicumpa W
    Asian Pac J Allergy Immunol; 2007 Dec; 25(4):233-42. PubMed ID: 18402297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus vaccine breakthrough infection: surveillance of S gene mutants of HBV.
    Qin Y; Liao P
    Acta Virol; 2018; 62(2):115-121. PubMed ID: 29895151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plant-based vaccines against human hepatitis B virus.
    Shchelkunov SN; Shchelkunova GA
    Expert Rev Vaccines; 2010 Aug; 9(8):947-55. PubMed ID: 20673016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oral vaccines--a future prospect! Hepatitis vaccination in the vegetable market?].
    Stiefelhagen P
    MMW Fortschr Med; 2003 Nov; 145(47):10. PubMed ID: 14725025
    [No Abstract]   [Full Text] [Related]  

  • 11. Production of hepatitis B surface antigen in recombinant plant systems: an update.
    Kumar GB; Ganapathi TR; Bapat VA
    Biotechnol Prog; 2007; 23(3):532-9. PubMed ID: 17348684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose oral immunization with lyophilized tissue of herbicide-resistant lettuce expressing hepatitis B surface antigen for prototype plant-derived vaccine tablet formulation.
    Pniewski T; Kapusta J; Bociąg P; Wojciechowicz J; Kostrzak A; Gdula M; Fedorowicz-Strońska O; Wójcik P; Otta H; Samardakiewicz S; Wolko B; Płucienniczak A
    J Appl Genet; 2011 May; 52(2):125-36. PubMed ID: 21107787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel, recombinant triple antigen hepatitis B vaccine (Hepacare).
    Page M; Jones CD; Bailey C
    Intervirology; 2001; 44(2-3):88-97. PubMed ID: 11509870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, immunization coverage and determinants of a new kind of Hepatitis B vaccine firstly applied in Ningbo, China.
    Yang S; Ma X; Ni H; Zhou S; Hu D; Shi H; Chen X; Dong H; Xu G
    Hum Vaccin Immunother; 2015; 11(12):2819-26. PubMed ID: 26211419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel chimeric Hepatitis B virus S/preS1 antigen produced in mammalian and plant cells elicits stronger humoral and cellular immune response than the standard vaccine-constituent, S protein.
    Dobrica MO; Lazar C; Paruch L; Skomedal H; Steen H; Haugslien S; Tucureanu C; Caras I; Onu A; Ciulean S; Branzan A; Clarke JL; Stavaru C; Branza-Nichita N
    Antiviral Res; 2017 Aug; 144():256-265. PubMed ID: 28666757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and immunoactivity of chimeric particulate antigens of receptor binding site-core antigen of hepatitis B virus.
    Yang HJ; Chen M; Cheng T; He SZ; Li SW; Guan BQ; Zhu ZH; Gu Y; Zhang J; Xia NS
    World J Gastroenterol; 2005 Jan; 11(4):492-7. PubMed ID: 15641132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of currently licensed hepatitis B surface antigen vaccines in the United States, Vaccine Adverse Event Reporting System (VAERS), 2005-2015.
    Haber P; Moro PL; Ng C; Lewis PW; Hibbs B; Schillie SF; Nelson NP; Li R; Stewart B; Cano MV
    Vaccine; 2018 Jan; 36(4):559-564. PubMed ID: 29241647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.
    Chow YH; Huang WL; Chi WK; Chu YD; Tao MH
    J Virol; 1997 Jan; 71(1):169-78. PubMed ID: 8985336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness.
    Stephenne J
    Vaccine; 1988 Aug; 6(4):299-303. PubMed ID: 2973187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The heritage of hepatitis B vaccine.
    Douglas RG
    JAMA; 1996 Dec; 276(22):1796-8. PubMed ID: 8946890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.